Claritev Corporation (CTEV)
NYSE: CTEV · Real-Time Price · USD
20.61
-0.16 (-0.77%)
Mar 31, 2025, 3:50 PM EDT - Market open
Claritev Market Cap
Claritev has a market cap or net worth of $333.84 million as of March 31, 2025. Its market cap has decreased by -37.92% in one year.
Market Cap
333.84M
Enterprise Value
4.87B
1-Year Change
-37.92%
Ranking
Category
Stock Price
$20.61
Market Cap Chart
Since April 3, 2020, Claritev's market cap has increased from $243.00M to $333.84M, an increase of 37.38%. That is a compound annual growth rate of 6.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 336.43M | 40.76% |
| Dec 31, 2024 | 239.01M | -74.44% |
| Dec 29, 2023 | 935.26M | 27.25% |
| Dec 30, 2022 | 734.99M | -74.01% |
| Dec 31, 2021 | 2.83B | -46.98% |
| Dec 31, 2020 | 5.33B | 2,094.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |